Polio Vaccine Industry Research Report 2024
Summary
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, the global Polio Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Polio Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polio Vaccine.
The report will help the Polio Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Polio Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polio Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Polio Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Polio Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, the global Polio Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Polio Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polio Vaccine.
The report will help the Polio Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Polio Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polio Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
- Public
- Private
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Polio Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Polio Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Polio Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Polio Vaccine Sales (2019-2030)
2.2.3 Global Polio Vaccine Market Average Price (2019-2030)
2.3 Polio Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Inactivated Polio Vaccine (IPV)
2.3.3 Oral Polio Vaccine (OPV)
2.4 Polio Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Public
2.4.3 Private
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Polio Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Polio Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Polio Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Polio Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Polio Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Polio Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Polio Vaccine, Product Type & Application
3.8 Global Manufacturers of Polio Vaccine, Date of Enter into This Industry
3.9 Global Polio Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Sanofi
4.1.1 Sanofi Company Information
4.1.2 Sanofi Business Overview
4.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Sanofi Polio Vaccine Product Portfolio
4.1.5 Sanofi Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK Polio Vaccine Product Portfolio
4.2.5 GSK Recent Developments
4.3 Bibcol
4.3.1 Bibcol Company Information
4.3.2 Bibcol Business Overview
4.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Bibcol Polio Vaccine Product Portfolio
4.3.5 Bibcol Recent Developments
4.4 Serum Institute
4.4.1 Serum Institute Company Information
4.4.2 Serum Institute Business Overview
4.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Serum Institute Polio Vaccine Product Portfolio
4.4.5 Serum Institute Recent Developments
4.5 Tiantan Biological
4.5.1 Tiantan Biological Company Information
4.5.2 Tiantan Biological Business Overview
4.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Tiantan Biological Polio Vaccine Product Portfolio
4.5.5 Tiantan Biological Recent Developments
4.6 IMBCA
4.6.1 IMBCA Company Information
4.6.2 IMBCA Business Overview
4.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 IMBCA Polio Vaccine Product Portfolio
4.6.5 IMBCA Recent Developments
4.7 Panacea Biotec Ltd
4.7.1 Panacea Biotec Ltd Company Information
4.7.2 Panacea Biotec Ltd Business Overview
4.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
4.7.5 Panacea Biotec Ltd Recent Developments
4.8 Bio-Med
4.8.1 Bio-Med Company Information
4.8.2 Bio-Med Business Overview
4.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Bio-Med Polio Vaccine Product Portfolio
4.8.5 Bio-Med Recent Developments
4.9 Halfkin Bio-Pharmaceuticals
4.9.1 Halfkin Bio-Pharmaceuticals Company Information
4.9.2 Halfkin Bio-Pharmaceuticals Business Overview
4.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
4.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
5 GLOBAL POLIO VACCINE MARKET SCENARIO BY REGION
5.1 Global Polio Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Polio Vaccine Sales by Region: 2019-2030
5.2.1 Global Polio Vaccine Sales by Region: 2019-2024
5.2.2 Global Polio Vaccine Sales by Region: 2025-2030
5.3 Global Polio Vaccine Revenue by Region: 2019-2030
5.3.1 Global Polio Vaccine Revenue by Region: 2019-2024
5.3.2 Global Polio Vaccine Revenue by Region: 2025-2030
5.4 North America Polio Vaccine Market Facts & Figures by Country
5.4.1 North America Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Polio Vaccine Sales by Country (2019-2030)
5.4.3 North America Polio Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Polio Vaccine Market Facts & Figures by Country
5.5.1 Europe Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Polio Vaccine Sales by Country (2019-2030)
5.5.3 Europe Polio Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Polio Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Polio Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Polio Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Polio Vaccine Market Facts & Figures by Country
5.7.1 Latin America Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Polio Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Polio Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Polio Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Polio Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Polio Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Polio Vaccine Sales by Type (2019-2030)
6.1.1 Global Polio Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Polio Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Polio Vaccine Revenue by Type (2019-2030)
6.2.1 Global Polio Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Polio Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Polio Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Polio Vaccine Sales by Application (2019-2030)
7.1.1 Global Polio Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Polio Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Polio Vaccine Revenue by Application (2019-2030)
7.2.1 Global Polio Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Polio Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Polio Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Polio Vaccine Value Chain Analysis
8.1.1 Polio Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Polio Vaccine Production Mode & Process
8.2 Polio Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Polio Vaccine Distributors
8.2.3 Polio Vaccine Customers
9 GLOBAL POLIO VACCINE ANALYZING MARKET DYNAMICS
9.1 Polio Vaccine Industry Trends
9.2 Polio Vaccine Industry Drivers
9.3 Polio Vaccine Industry Opportunities and Challenges
9.4 Polio Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Polio Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Polio Vaccine Sales (2019-2030)
2.2.3 Global Polio Vaccine Market Average Price (2019-2030)
2.3 Polio Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Inactivated Polio Vaccine (IPV)
2.3.3 Oral Polio Vaccine (OPV)
2.4 Polio Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Public
2.4.3 Private
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Polio Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Polio Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Polio Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Polio Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Polio Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Polio Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Polio Vaccine, Product Type & Application
3.8 Global Manufacturers of Polio Vaccine, Date of Enter into This Industry
3.9 Global Polio Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Sanofi
4.1.1 Sanofi Company Information
4.1.2 Sanofi Business Overview
4.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Sanofi Polio Vaccine Product Portfolio
4.1.5 Sanofi Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK Polio Vaccine Product Portfolio
4.2.5 GSK Recent Developments
4.3 Bibcol
4.3.1 Bibcol Company Information
4.3.2 Bibcol Business Overview
4.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Bibcol Polio Vaccine Product Portfolio
4.3.5 Bibcol Recent Developments
4.4 Serum Institute
4.4.1 Serum Institute Company Information
4.4.2 Serum Institute Business Overview
4.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Serum Institute Polio Vaccine Product Portfolio
4.4.5 Serum Institute Recent Developments
4.5 Tiantan Biological
4.5.1 Tiantan Biological Company Information
4.5.2 Tiantan Biological Business Overview
4.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Tiantan Biological Polio Vaccine Product Portfolio
4.5.5 Tiantan Biological Recent Developments
4.6 IMBCA
4.6.1 IMBCA Company Information
4.6.2 IMBCA Business Overview
4.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 IMBCA Polio Vaccine Product Portfolio
4.6.5 IMBCA Recent Developments
4.7 Panacea Biotec Ltd
4.7.1 Panacea Biotec Ltd Company Information
4.7.2 Panacea Biotec Ltd Business Overview
4.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
4.7.5 Panacea Biotec Ltd Recent Developments
4.8 Bio-Med
4.8.1 Bio-Med Company Information
4.8.2 Bio-Med Business Overview
4.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Bio-Med Polio Vaccine Product Portfolio
4.8.5 Bio-Med Recent Developments
4.9 Halfkin Bio-Pharmaceuticals
4.9.1 Halfkin Bio-Pharmaceuticals Company Information
4.9.2 Halfkin Bio-Pharmaceuticals Business Overview
4.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
4.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
5 GLOBAL POLIO VACCINE MARKET SCENARIO BY REGION
5.1 Global Polio Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Polio Vaccine Sales by Region: 2019-2030
5.2.1 Global Polio Vaccine Sales by Region: 2019-2024
5.2.2 Global Polio Vaccine Sales by Region: 2025-2030
5.3 Global Polio Vaccine Revenue by Region: 2019-2030
5.3.1 Global Polio Vaccine Revenue by Region: 2019-2024
5.3.2 Global Polio Vaccine Revenue by Region: 2025-2030
5.4 North America Polio Vaccine Market Facts & Figures by Country
5.4.1 North America Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Polio Vaccine Sales by Country (2019-2030)
5.4.3 North America Polio Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Polio Vaccine Market Facts & Figures by Country
5.5.1 Europe Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Polio Vaccine Sales by Country (2019-2030)
5.5.3 Europe Polio Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Polio Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Polio Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Polio Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Polio Vaccine Market Facts & Figures by Country
5.7.1 Latin America Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Polio Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Polio Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Polio Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Polio Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Polio Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Polio Vaccine Sales by Type (2019-2030)
6.1.1 Global Polio Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Polio Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Polio Vaccine Revenue by Type (2019-2030)
6.2.1 Global Polio Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Polio Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Polio Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Polio Vaccine Sales by Application (2019-2030)
7.1.1 Global Polio Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Polio Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Polio Vaccine Revenue by Application (2019-2030)
7.2.1 Global Polio Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Polio Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Polio Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Polio Vaccine Value Chain Analysis
8.1.1 Polio Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Polio Vaccine Production Mode & Process
8.2 Polio Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Polio Vaccine Distributors
8.2.3 Polio Vaccine Customers
9 GLOBAL POLIO VACCINE ANALYZING MARKET DYNAMICS
9.1 Polio Vaccine Industry Trends
9.2 Polio Vaccine Industry Drivers
9.3 Polio Vaccine Industry Opportunities and Challenges
9.4 Polio Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Polio Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Polio Vaccine Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Polio Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Polio Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Polio Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Polio Vaccine Average Price (USD/K Doses) of Manufacturers (2018-2023)
Table 11. Global Polio Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Polio Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Polio Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Sanofi Company Information
Table 17. Sanofi Business Overview
Table 18. Sanofi Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 19. Sanofi Polio Vaccine Product Portfolio
Table 20. Sanofi Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 24. GSK Polio Vaccine Product Portfolio
Table 25. GSK Recent Developments
Table 26. Bibcol Company Information
Table 27. Bibcol Business Overview
Table 28. Bibcol Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 29. Bibcol Polio Vaccine Product Portfolio
Table 30. Bibcol Recent Developments
Table 31. Serum Institute Company Information
Table 32. Serum Institute Business Overview
Table 33. Serum Institute Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 34. Serum Institute Polio Vaccine Product Portfolio
Table 35. Serum Institute Recent Developments
Table 36. Tiantan Biological Company Information
Table 37. Tiantan Biological Business Overview
Table 38. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 39. Tiantan Biological Polio Vaccine Product Portfolio
Table 40. Tiantan Biological Recent Developments
Table 41. IMBCA Company Information
Table 42. IMBCA Business Overview
Table 43. IMBCA Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 44. IMBCA Polio Vaccine Product Portfolio
Table 45. IMBCA Recent Developments
Table 46. Panacea Biotec Ltd Company Information
Table 47. Panacea Biotec Ltd Business Overview
Table 48. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 49. Panacea Biotec Ltd Polio Vaccine Product Portfolio
Table 50. Panacea Biotec Ltd Recent Developments
Table 51. Bio-Med Company Information
Table 52. Bio-Med Business Overview
Table 53. Bio-Med Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 54. Bio-Med Polio Vaccine Product Portfolio
Table 55. Bio-Med Recent Developments
Table 56. Halfkin Bio-Pharmaceuticals Company Information
Table 57. Halfkin Bio-Pharmaceuticals Business Overview
Table 58. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 59. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
Table 60. Halfkin Bio-Pharmaceuticals Recent Developments
Table 61. Global Polio Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 62. Global Polio Vaccine Sales by Region (2018-2023) & (M Doses)
Table 63. Global Polio Vaccine Sales Market Share by Region (2018-2023)
Table 64. Global Polio Vaccine Sales by Region (2024-2029) & (M Doses)
Table 65. Global Polio Vaccine Sales Market Share by Region (2024-2029)
Table 66. Global Polio Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 67. Global Polio Vaccine Revenue Market Share by Region (2018-2023)
Table 68. Global Polio Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 69. Global Polio Vaccine Revenue Market Share by Region (2024-2029)
Table 70. North America Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. North America Polio Vaccine Sales by Country (2018-2023) & (M Doses)
Table 72. North America Polio Vaccine Sales by Country (2024-2029) & (M Doses)
Table 73. North America Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 74. North America Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Europe Polio Vaccine Sales by Country (2018-2023) & (M Doses)
Table 77. Europe Polio Vaccine Sales by Country (2024-2029) & (M Doses)
Table 78. Europe Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 79. Europe Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 80. Asia Pacific Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Asia Pacific Polio Vaccine Sales by Country (2018-2023) & (M Doses)
Table 82. Asia Pacific Polio Vaccine Sales by Country (2024-2029) & (M Doses)
Table 83. Asia Pacific Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 84. Asia Pacific Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 85. Latin America Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Latin America Polio Vaccine Sales by Country (2018-2023) & (M Doses)
Table 87. Latin America Polio Vaccine Sales by Country (2024-2029) & (M Doses)
Table 88. Latin America Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 89. Latin America Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 90. Middle East and Africa Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Middle East and Africa Polio Vaccine Sales by Country (2018-2023) & (M Doses)
Table 92. Middle East and Africa Polio Vaccine Sales by Country (2024-2029) & (M Doses)
Table 93. Middle East and Africa Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 94. Middle East and Africa Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 95. Global Polio Vaccine Sales by Type (2018-2023) & (M Doses)
Table 96. Global Polio Vaccine Sales by Type (2024-2029) & (M Doses)
Table 97. Global Polio Vaccine Sales Market Share by Type (2018-2023)
Table 98. Global Polio Vaccine Sales Market Share by Type (2024-2029)
Table 99. Global Polio Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 100. Global Polio Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 101. Global Polio Vaccine Revenue Market Share by Type (2018-2023)
Table 102. Global Polio Vaccine Revenue Market Share by Type (2024-2029)
Table 103. Global Polio Vaccine Price by Type (2018-2023) & (USD/K Doses)
Table 104. Global Polio Vaccine Price by Type (2024-2029) & (USD/K Doses)
Table 105. Global Polio Vaccine Sales by Application (2018-2023) & (M Doses)
Table 106. Global Polio Vaccine Sales by Application (2024-2029) & (M Doses)
Table 107. Global Polio Vaccine Sales Market Share by Application (2018-2023)
Table 108. Global Polio Vaccine Sales Market Share by Application (2024-2029)
Table 109. Global Polio Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 110. Global Polio Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 111. Global Polio Vaccine Revenue Market Share by Application (2018-2023)
Table 112. Global Polio Vaccine Revenue Market Share by Application (2024-2029)
Table 113. Global Polio Vaccine Price by Application (2018-2023) & (USD/K Doses)
Table 114. Global Polio Vaccine Price by Application (2024-2029) & (USD/K Doses)
Table 115. Key Raw Materials
Table 116. Raw Materials Key Suppliers
Table 117. Polio Vaccine Distributors List
Table 118. Polio Vaccine Customers List
Table 119. Polio Vaccine Industry Trends
Table 120. Polio Vaccine Industry Drivers
Table 121. Polio Vaccine Industry Restraints
Table 122. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Polio Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Polio Vaccine Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Polio Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Polio Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Polio Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Polio Vaccine Average Price (USD/K Doses) of Manufacturers (2018-2023)
Table 11. Global Polio Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Polio Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Polio Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Sanofi Company Information
Table 17. Sanofi Business Overview
Table 18. Sanofi Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 19. Sanofi Polio Vaccine Product Portfolio
Table 20. Sanofi Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 24. GSK Polio Vaccine Product Portfolio
Table 25. GSK Recent Developments
Table 26. Bibcol Company Information
Table 27. Bibcol Business Overview
Table 28. Bibcol Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 29. Bibcol Polio Vaccine Product Portfolio
Table 30. Bibcol Recent Developments
Table 31. Serum Institute Company Information
Table 32. Serum Institute Business Overview
Table 33. Serum Institute Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 34. Serum Institute Polio Vaccine Product Portfolio
Table 35. Serum Institute Recent Developments
Table 36. Tiantan Biological Company Information
Table 37. Tiantan Biological Business Overview
Table 38. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 39. Tiantan Biological Polio Vaccine Product Portfolio
Table 40. Tiantan Biological Recent Developments
Table 41. IMBCA Company Information
Table 42. IMBCA Business Overview
Table 43. IMBCA Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 44. IMBCA Polio Vaccine Product Portfolio
Table 45. IMBCA Recent Developments
Table 46. Panacea Biotec Ltd Company Information
Table 47. Panacea Biotec Ltd Business Overview
Table 48. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 49. Panacea Biotec Ltd Polio Vaccine Product Portfolio
Table 50. Panacea Biotec Ltd Recent Developments
Table 51. Bio-Med Company Information
Table 52. Bio-Med Business Overview
Table 53. Bio-Med Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 54. Bio-Med Polio Vaccine Product Portfolio
Table 55. Bio-Med Recent Developments
Table 56. Halfkin Bio-Pharmaceuticals Company Information
Table 57. Halfkin Bio-Pharmaceuticals Business Overview
Table 58. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 59. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
Table 60. Halfkin Bio-Pharmaceuticals Recent Developments
Table 61. Global Polio Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 62. Global Polio Vaccine Sales by Region (2018-2023) & (M Doses)
Table 63. Global Polio Vaccine Sales Market Share by Region (2018-2023)
Table 64. Global Polio Vaccine Sales by Region (2024-2029) & (M Doses)
Table 65. Global Polio Vaccine Sales Market Share by Region (2024-2029)
Table 66. Global Polio Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 67. Global Polio Vaccine Revenue Market Share by Region (2018-2023)
Table 68. Global Polio Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 69. Global Polio Vaccine Revenue Market Share by Region (2024-2029)
Table 70. North America Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. North America Polio Vaccine Sales by Country (2018-2023) & (M Doses)
Table 72. North America Polio Vaccine Sales by Country (2024-2029) & (M Doses)
Table 73. North America Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 74. North America Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Europe Polio Vaccine Sales by Country (2018-2023) & (M Doses)
Table 77. Europe Polio Vaccine Sales by Country (2024-2029) & (M Doses)
Table 78. Europe Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 79. Europe Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 80. Asia Pacific Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Asia Pacific Polio Vaccine Sales by Country (2018-2023) & (M Doses)
Table 82. Asia Pacific Polio Vaccine Sales by Country (2024-2029) & (M Doses)
Table 83. Asia Pacific Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 84. Asia Pacific Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 85. Latin America Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Latin America Polio Vaccine Sales by Country (2018-2023) & (M Doses)
Table 87. Latin America Polio Vaccine Sales by Country (2024-2029) & (M Doses)
Table 88. Latin America Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 89. Latin America Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 90. Middle East and Africa Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Middle East and Africa Polio Vaccine Sales by Country (2018-2023) & (M Doses)
Table 92. Middle East and Africa Polio Vaccine Sales by Country (2024-2029) & (M Doses)
Table 93. Middle East and Africa Polio Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 94. Middle East and Africa Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 95. Global Polio Vaccine Sales by Type (2018-2023) & (M Doses)
Table 96. Global Polio Vaccine Sales by Type (2024-2029) & (M Doses)
Table 97. Global Polio Vaccine Sales Market Share by Type (2018-2023)
Table 98. Global Polio Vaccine Sales Market Share by Type (2024-2029)
Table 99. Global Polio Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 100. Global Polio Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 101. Global Polio Vaccine Revenue Market Share by Type (2018-2023)
Table 102. Global Polio Vaccine Revenue Market Share by Type (2024-2029)
Table 103. Global Polio Vaccine Price by Type (2018-2023) & (USD/K Doses)
Table 104. Global Polio Vaccine Price by Type (2024-2029) & (USD/K Doses)
Table 105. Global Polio Vaccine Sales by Application (2018-2023) & (M Doses)
Table 106. Global Polio Vaccine Sales by Application (2024-2029) & (M Doses)
Table 107. Global Polio Vaccine Sales Market Share by Application (2018-2023)
Table 108. Global Polio Vaccine Sales Market Share by Application (2024-2029)
Table 109. Global Polio Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 110. Global Polio Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 111. Global Polio Vaccine Revenue Market Share by Application (2018-2023)
Table 112. Global Polio Vaccine Revenue Market Share by Application (2024-2029)
Table 113. Global Polio Vaccine Price by Application (2018-2023) & (USD/K Doses)
Table 114. Global Polio Vaccine Price by Application (2024-2029) & (USD/K Doses)
Table 115. Key Raw Materials
Table 116. Raw Materials Key Suppliers
Table 117. Polio Vaccine Distributors List
Table 118. Polio Vaccine Customers List
Table 119. Polio Vaccine Industry Trends
Table 120. Polio Vaccine Industry Drivers
Table 121. Polio Vaccine Industry Restraints
Table 122. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Polio VaccineProduct Picture
Figure 5. Global Polio Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Polio Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Polio Vaccine Sales (2018-2029) & (M Doses)
Figure 8. Global Polio Vaccine Average Price (USD/K Doses) & (2018-2029)
Figure 9. Inactivated Polio Vaccine (IPV) Product Picture
Figure 10. Oral Polio Vaccine (OPV) Product Picture
Figure 11. Public Product Picture
Figure 12. Private Product Picture
Figure 13. Global Polio Vaccine Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of Polio Vaccine, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of Polio Vaccine, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 Polio Vaccine Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global Polio Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global Polio Vaccine Sales by Region in 2022
Figure 20. Global Polio Vaccine Revenue by Region in 2022
Figure 21. North America Polio Vaccine Market Size by Country in 2022
Figure 22. North America Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 23. North America Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Polio Vaccine Market Size by Country in 2022
Figure 27. Europe Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 28. Europe Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 29. Germany Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Polio Vaccine Market Size by Country in 2022
Figure 35. Asia Pacific Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 37. China Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Polio Vaccine Market Size by Country in 2022
Figure 47. Latin America Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Latin America Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East and Africa Polio Vaccine Market Size by Country in 2022
Figure 53. Middle East and Africa Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 54. Middle East and Africa Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Polio Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Global Polio Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Global Polio Vaccine Price (USD/K Doses) by Type (2018-2029)
Figure 61. Global Polio Vaccine Sales Market Share by Application (2018-2029)
Figure 62. Global Polio Vaccine Revenue Market Share by Application (2018-2029)
Figure 63. Global Polio Vaccine Price (USD/K Doses) by Application (2018-2029)
Figure 64. Polio Vaccine Value Chain
Figure 65. Polio Vaccine Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Polio Vaccine Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Polio VaccineProduct Picture
Figure 5. Global Polio Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Polio Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Polio Vaccine Sales (2018-2029) & (M Doses)
Figure 8. Global Polio Vaccine Average Price (USD/K Doses) & (2018-2029)
Figure 9. Inactivated Polio Vaccine (IPV) Product Picture
Figure 10. Oral Polio Vaccine (OPV) Product Picture
Figure 11. Public Product Picture
Figure 12. Private Product Picture
Figure 13. Global Polio Vaccine Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of Polio Vaccine, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of Polio Vaccine, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 Polio Vaccine Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global Polio Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global Polio Vaccine Sales by Region in 2022
Figure 20. Global Polio Vaccine Revenue by Region in 2022
Figure 21. North America Polio Vaccine Market Size by Country in 2022
Figure 22. North America Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 23. North America Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Polio Vaccine Market Size by Country in 2022
Figure 27. Europe Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 28. Europe Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 29. Germany Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Polio Vaccine Market Size by Country in 2022
Figure 35. Asia Pacific Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 37. China Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Polio Vaccine Market Size by Country in 2022
Figure 47. Latin America Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Latin America Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East and Africa Polio Vaccine Market Size by Country in 2022
Figure 53. Middle East and Africa Polio Vaccine Sales Market Share by Country (2018-2029)
Figure 54. Middle East and Africa Polio Vaccine Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Polio Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Polio Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Global Polio Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Global Polio Vaccine Price (USD/K Doses) by Type (2018-2029)
Figure 61. Global Polio Vaccine Sales Market Share by Application (2018-2029)
Figure 62. Global Polio Vaccine Revenue Market Share by Application (2018-2029)
Figure 63. Global Polio Vaccine Price (USD/K Doses) by Application (2018-2029)
Figure 64. Polio Vaccine Value Chain
Figure 65. Polio Vaccine Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Polio Vaccine Industry Opportunities and Challenges
